Kunitaka Shibata
About
In The Last Decade
Kunitaka Shibata
32 papers receiving 334 citations
Peers
Comparison fields: 5 of 46
- Hepatology 210
- Epidemiology 189
- Surgery 107
- Oncology 75
- Radiology, Nuclear Medicine and Imaging 73
Countries citing papers authored by Kunitaka Shibata
This map shows the geographic impact of Kunitaka Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunitaka Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunitaka Shibata more than expected).
Fields of papers citing papers by Kunitaka Shibata
This network shows the impact of papers produced by Kunitaka Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunitaka Shibata. The network helps show where Kunitaka Shibata may publish in the future.
Co-authorship network of co-authors of Kunitaka Shibata
This figure shows the co-authorship network connecting the top 25 collaborators of Kunitaka Shibata. A scholar is included among the top collaborators of Kunitaka Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunitaka Shibata. Kunitaka Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | [A Case Report of Long Survival in Pancreatic Cancer with Superior Mesenteric Arterial Invasion Following Multimodal Therapy]. | 1 |
| 3 | [A Case of Chemotherapy with Abscess Drainage for Pancreatic Cancer Detected Due to Peritonitis]. | 1 |
| 4 | [Adjuvant Chemotherapy and the Prognosis of ypStageⅠ Gastric Cancer]. | 1 |
| 5 | [A Case Report of Advanced Gastric Cancer with Synchronous Liver Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy]. | 1 |
| 6 | 1 | |
| 7 | [A Case of Urothelial Carcinoma Who Underwent Pancreaticoduodenectomy and Was Diagnosed with Groove Pancreatitis and Preoperatively Suffered from Duodenal Stenosis]. | 4 |
| 8 | [A Case of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis Achieving Recurrence-Free Survival for Five Years by Gastrectomy, Hepatectomy, and Adjuvant Chemotherapy]. | 1 |
| 9 | 1 | |
| 10 | 5 | |
| 11 | [A case report of gastric small cell carcinoma with long survival time by adjuvant chemotherapy--reports of chemotherapy regimens for gastric small cell carcinoma]. | 4 |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 6 | |
| 15 | 180 | |
| 16 | 25 | |
| 17 | 1 | |
| 18 | [Localized pulmonary infiltration in chronic myelomonocytic leukemia]. | 1 |
| 19 | 4 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.